Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-25-000098
Filing Date
2025-08-05
Accepted
2025-08-05 17:00:19
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eols-20250630.htm   iXBRL 10-Q 1395381
2 EX-10.1 a6302510-qex101.htm EX-10.1 1115315
3 EX-31.1 exhibit311q22025.htm EX-31.1 10455
4 EX-31.2 exhibit312q22025.htm EX-31.2 10682
5 EX-32.1 exhibit321q22025.htm EX-32.1 6456
  Complete submission text file 0001570562-25-000098.txt   9158854

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20250630.xsd EX-101.SCH 55717
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20250630_cal.xml EX-101.CAL 75485
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20250630_def.xml EX-101.DEF 306091
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20250630_lab.xml EX-101.LAB 736080
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20250630_pre.xml EX-101.PRE 512518
74 EXTRACTED XBRL INSTANCE DOCUMENT eols-20250630_htm.xml XML 988316
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 251185964
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)